Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
ANAB
AnaptysBio
$30.94
Login to see AnaptysBio (ANAB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Upgraded on attractively valued
Outperform the market
Chart
$22.13 (+39.81%)
$26.95 (+14.81%)
$19.44 (+59.16%)
$34.98 (-11.55%)
ANAB has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
ANAB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Outperform the market
ANAB Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ANAB Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayANAB Earnings
The TTM reflects 12-month period, providing review of ANAB financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is ANAB current stock price?
What are ANAB stock strengths?
What risks are associated with ANAB stock?
When is ANAB next earnings report?
What is ANAB market cap and volume?
What is ANAB's current Stock IQ?
Should I buy ANAB stock right now?
Is ANAB a Strong Buy right now?
What does a 'Strong Buy' rating mean for ANAB?
What does a 'Strong Sell' rating mean for ANAB?
What factors influence ANAB's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
ANAB
AnaptysBio
Current Price
$30.94
Stock Insights
Strengths
Upgraded on attractively valued
Outperform the market
Login to unlock AnaptysBio (ANAB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$22.13 (+39.81%)
$26.95 (+14.81%)
$19.44 (+59.16%)
$34.98 (-11.55%)
ANAB Analysts Opinion
ANAB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Outperform the market
ANAB Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ANAB Street view is extremely bullish and have positive views on the near-term outlook
ANAB has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayANAB Earnings
The TTM data reflects the most recent 12-month period, providing overview of ANAB financial performance.
ANAB Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
ANAB Latest Analysis
Wedbush Reiterates AnaptysBio (ANAB) Outperform Recommendation. Fintel reports that on September 30 2025 Wedbush reiterated coverage of AnaptysBio (NasdaqGS:ANAB) with a Outperform recommendation. Analyst Price Forecast Suggests 55.28% Upside
Wed Oct 1, 2025
HC Wainwright & Co. Maintains AnaptysBio (ANAB) Buy Recommendation. Fintel reports that on September 30 2025 HC Wainwright &. Co. maintained coverage of AnaptysBio (NasdaqGS:ANAB) with a Buy recommendation. Analyst Price Forecast Suggests 104.26% Upside
Tue Sep 30, 2025
AnaptysBio stock price target raised to $59 from $38 at H.C. Wainwright.
Tue Sep 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ANAB Stock trends
ANAB Stock performance
ANAB Stock analysis
ANAB investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings